title: Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin/integrin β1/FAK axis.
abstract: The aryl hydrocarbon receptor nuclear translocator (ARNT) is broadly involved in regulating tumorigenesis by inducing genes that are involved in tumor growth and angiogenesis. Tumorigenesis usually involves normoxic conditions. However, the role of ARNT in tumor metastasis during normoxia remains unclear. Here, we demonstrate that ARNT protein levels were decreased in late-stage human colorectal cancer using immunohistochemical analysis. Down-regulation of ARNT protein promoted cancer cell migration and invasion, which was mediated by activation of the fibronectin/integrin β1/FAK signaling axis. In addition, the enhancement of migration and invasion in ANRT knockdown cells was blocked when ARNT was restored in the cells. In xenografts in severe combined immunodeficiency mice, tumor growth was significantly inhibited in the ARNT-knockdown condition. However, the tail-vein injection animal model revealed that the depletion of ARNT-induced metastatic lung colonies was further enhanced when ARNT expression was recovered post-injection. Interestingly, chemotherapeutic drugs inhibited ARNT expression and promoted the invasion of residual tumor cells. These results suggest that ARNT may play a positive role during tumor growth (either in early-stage tumor growth or in organ metastases), but plays a negative role in tumor migration and invasion. Therefore, the efficiency of ARNT-targeted therapy during different cancer stages should be carefully evaluated.
authors.affiliation: Institute of Bioinformatics and Biosignal Transduction, College of Bioscience and Biotechnology, National Cheng Kung University, Taiwan, ROC.|Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taiwan, ROC.
authors.forename: Chi-Ruei
authors.initials: CR
authors.lastname: Huang
authors.affiliation: Department of Pathology, National Cheng Kung University Hospital, Taiwan, ROC.
authors.forename: Chung-Ta
authors.initials: CT
authors.lastname: Lee
authors.affiliation: National Institute of Cancer Research, National Health Research Institutes, Taiwan, ROC.|Division of Hematology/Oncology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Taiwan, ROC.
authors.forename: Kwang-Yu
authors.initials: KY
authors.lastname: Chang
authors.affiliation: Graduate Institute of Medical Sciences, College of Medicine, Taipei Medical University, Taiwan, ROC.
authors.forename: Wen-Chang
authors.initials: WC
authors.lastname: Chang
authors.affiliation: Department of Pathology, Kuo General Hospital, Taiwan, ROC.
authors.forename: Yao-Wen
authors.initials: YW
authors.lastname: Liu
authors.affiliation: Department of Surgery, National Cheng Kung University Hospital, Taiwan, ROC.
authors.forename: Jenq-Chang
authors.initials: JC
authors.lastname: Lee
authors.affiliation: Institute of Bioinformatics and Biosignal Transduction, College of Bioscience and Biotechnology, National Cheng Kung University, Taiwan, ROC.|Department of Pharmacology, College of Medicine, National Cheng Kung University, Taiwan, ROC.|Institute for Cancer Biology and Drug Discovery, College of Medical Science and Technology, Taipei Medical University, Taiwan, ROC.
authors.forename: Ben-Kuen
authors.initials: BK
authors.lastname: Chen
mesh_terms: D000230:Adenocarcinoma / Q000201:enzymology* / Q000235:genetics / Q000556:secondary; D000818:Animals; D051784:Aryl Hydrocarbon Receptor Nuclear Translocator / Q000235:genetics / Q000378:metabolism*; D045744:Cell Line, Tumor; D002465:Cell Movement; D003110:Colonic Neoplasms / Q000201:enzymology* / Q000235:genetics / Q000473:pathology; D005353:Fibronectins / Q000235:genetics / Q000378:metabolism*; D051417:Focal Adhesion Kinase 1 / Q000235:genetics / Q000378:metabolism*; D015972:Gene Expression Regulation, Neoplastic; D064593:Heterografts; D006801:Humans; D019012:Integrin beta1 / Q000235:genetics / Q000378:metabolism*; D008175:Lung Neoplasms / Q000201:enzymology* / Q000235:genetics / Q000556:secondary; D008297:Male; D016513:Mice, SCID; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging; D034622:RNA Interference; D015398:Signal Transduction; D013997:Time Factors; D014162:Transfection
chemical_list: C497396:ARNT protein, human; D005353:Fibronectins; D019012:Integrin beta1; D051784:Aryl Hydrocarbon Receptor Nuclear Translocator; D051417:Focal Adhesion Kinase 1; C496050:PTK2 protein, human
keywords: ARNT; ROS; metastasis; oncogene
references.citation: Nucleic Acids Res. 2011 Jan;39(2):440-53
references.pmid: 20833636
references.citation: Cell Mol Life Sci. 2010 Oct;67(20):3523-33
references.pmid: 20508969
references.citation: J Cell Biochem. 2011 Oct;112(10):2850-64
references.pmid: 21618587
references.citation: Am J Physiol Heart Circ Physiol. 2011 Oct;301(4):H1519-30
references.pmid: 21841015
references.citation: Cancer Res. 2011 Nov 15;71(22):6976-85
references.pmid: 21975929
references.citation: Int J Cancer. 2012 Apr 15;130(8):1745-54
references.pmid: 21544813
references.citation: Nature. 2012 Mar 29;483(7391):603-7
references.pmid: 22460905
references.citation: J Neurooncol. 2012 Jul;108(3):349-60
references.pmid: 22382783
references.citation: Cancer Res. 2012 Jul 15;72(14):3631-41
references.pmid: 22593189
references.citation: Mol Cancer Ther. 2014 Aug;13(8):2081-91
references.pmid: 24928850
references.citation: J Pathol. 2014 Nov;234(3):351-64
references.pmid: 25042645
references.citation: Cancer Med. 2014 Oct;3(5):1099-111
references.pmid: 24961511
references.citation: Biochem J. 1997 May 15;324 ( Pt 1):133-40
references.pmid: 9164849
references.citation: Proc Natl Acad Sci U S A. 2000 Jun 6;97(12):6757-62
references.pmid: 10829078
references.citation: Clin Cancer Res. 2001 Apr;7(4):818-23
references.pmid: 11309328
references.citation: Science. 2001 Apr 20;292(5516):464-8
references.pmid: 11292862
references.citation: Annu Rev Med. 2002;53:615-27
references.pmid: 11818492
references.citation: Oncogene. 2002 Jul 18;21(31):4855-62
references.pmid: 12101425
references.citation: Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9990-5
references.pmid: 12107286
references.citation: Chem Biol Interact. 2002 Sep 20;141(1-2):117-30
references.pmid: 12213388
references.citation: J Cell Sci. 2002 Oct 15;115(Pt 20):3861-3
references.pmid: 12244123
references.citation: Int J Biochem Cell Biol. 2004 Feb;36(2):189-204
references.pmid: 14643885
references.citation: Nat Rev Drug Discov. 2003 Oct;2(10):803-11
references.pmid: 14526383
references.citation: Cell. 2002 Sep 20;110(6):673-87
references.pmid: 12297042
references.citation: Neoplasia. 2004 Jan-Feb;6(1):1-6
references.pmid: 15068665
references.citation: Nat Rev Mol Cell Biol. 2004 May;5(5):343-54
references.pmid: 15122348
references.citation: Oncogene. 2012 Aug 30;31(35):3973-88
references.pmid: 22158040
references.citation: Cancer Res. 2012 Oct 15;72(20):5407-17
references.pmid: 22915755
references.citation: Mol Carcinog. 2013 Jan;52(1):29-38
references.pmid: 22012870
references.citation: Am J Physiol Renal Physiol. 2013 May 15;304(10):F1266-73
references.pmid: 23408168
references.citation: Mol Pharmacol. 2013 Oct;84(4):591-602
references.pmid: 23907215
references.citation: PLoS One. 2014;9(6):e99242
references.pmid: 24921657
references.citation: PLoS One. 2014;9(7):e101330
references.pmid: 24992599
references.citation: BMC Cancer. 2014;14:498
references.pmid: 25011475
references.citation: Eur J Biochem. 1997 Jun 1;246(2):486-95
references.pmid: 9208942
references.citation: Int J Radiat Oncol Biol Phys. 1998 Nov 1;42(4):913-6
references.pmid: 9845121
references.citation: Kidney Int. 2006 May;69(9):1593-600
references.pmid: 16572112
references.citation: Genes Dev. 2006 Oct 1;20(19):2648-53
references.pmid: 17015429
references.citation: Mol Cancer Res. 2007 Jan;5(1):1-10
references.pmid: 17259342
references.citation: Mol Cell Biol. 2007 Mar;27(5):1859-67
references.pmid: 17194750
references.citation: Toxicol Sci. 2007 Aug;98(2):436-44
references.pmid: 17517823
references.citation: Genome Biol. 2007;8(7):R131
references.pmid: 17615082
references.citation: J Biol Chem. 2009 Apr 10;284(15):9908-16
references.pmid: 19203995
references.citation: Carcinogenesis. 2009 Nov;30(11):1957-61
references.pmid: 19755658
references.citation: Mol Carcinog. 2010 Feb;49(2):157-65
references.pmid: 19824022
references.citation: Nature. 2010 Feb 18;463(7283):899-905
references.pmid: 20164920
references.citation: Proc Natl Acad Sci U S A. 2010 Apr 6;107(14):6334-9
references.pmid: 20308559
references.citation: Mol Carcinog. 2010 May;49(5):476-87
references.pmid: 20232364
references.citation: Mol Cancer. 2010;9:108
references.pmid: 20478051
references.citation: Cancer Genet Cytogenet. 2010 Oct 1;202(1):22-6
references.pmid: 20804916
references.citation: Genes Chromosomes Cancer. 2010 Nov;49(11):1024-34
references.pmid: 20725992
references.citation: Science. 2011 Mar 25;331(6024):1559-64
references.pmid: 21436443